Graypoint LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Graypoint LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$1,483
-25.8%
13,4200.0%0.00%
Q3 2022$2,000
-33.3%
13,4200.0%0.00%
Q2 2022$3,000
-57.1%
13,4200.0%0.00%
-100.0%
Q1 2022$7,000
-12.5%
13,4200.0%0.00%0.0%
Q4 2021$8,000
-42.9%
13,4200.0%0.00%
-50.0%
Q3 2021$14,000
-44.0%
13,4200.0%0.00%
-33.3%
Q2 2021$25,00013,4200.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders